Cargando...

The efficacy and safety of oral disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review

Background: Although widely used, first-line injectable medicines for the treatment of multiple sclerosis (MS) remain an issue of efficacy and adherence. Recently, new oral medications for MS have contributed to dramatic improvements in MS treatment. This study aims to evaluate the safety and effica...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Curr J Neurol
Main Authors: Shahtaheri, Rahil Sadat, Nikfar, Shekoufeh, Khorasani, Elahe, Sabbagh-Baniazad, Mansoureh, Goudarzi, Zahra, Emamikhah, Maziar
Formato: Artigo
Idioma:Inglês
Publicado: Tehran University of Medical Sciences 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8185589/
https://ncbi.nlm.nih.gov/pubmed/38011404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18502/cjn.v19i3.5427
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!